Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice

Fig. 2

rTgADF-specific sIgA antibody responses in the mucosal washes. Nasal, intestinal, and vesical washes were harvested from the immunized (different doses of rTgADF) and control mice (PBS) two weeks after the last immunization. The sIgA antibodies were detected using ELISA. Results are expressed as mean ± SD (n = 8) for three independent experiments. *, P < 0.05 compared to the PBS group; a, P < 0.05 compared to the 20-μg group. b, P < 0.05 compared to the 40-μg group

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us